# FDA Inspection 1220204 - Linhai Tianyu Pharmaceutical Co., Ltd. - September 15, 2023

Source: https://www.keypedia.com/records/fda_inspections/linhai-tianyu-pharmaceutical-co-ltd/192b8206-ac93-497b-9411-d93c83f8515a
Source feed: FDA_Inspections

> FDA Inspection 1220204 for Linhai Tianyu Pharmaceutical Co., Ltd. on September 15, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1220204
- Company Name: Linhai Tianyu Pharmaceutical Co., Ltd.
- Inspection Date: 2023-09-15
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1088247 - 2019-04-19](https://www.keypedia.com/records/fda_inspections/linhai-tianyu-pharmaceutical-co-ltd/6dcd8a5b-842c-4ef1-8b8e-f939632a1f3b)

Company: https://www.keypedia.com/companies/linhai-tianyu-pharmaceutical-co-ltd/0ec07318-0eee-4a4c-84a5-1bbd812ebfcf

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c